Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients.
Teixeira PC, Dorneles GP, Santana Filho PC, da Silva IM, Schipper LL, Postiga IAL, Neves CAM, Rodrigues Junior LC, Peres A, Souto JT, Fonseca SG, Eller S, Oliveira TF, Rotta LN, Thompson CE, Romão PRT.
Teixeira PC, et al. Among authors: rotta ln.
Int Immunopharmacol. 2021 Nov;100:108125. doi: 10.1016/j.intimp.2021.108125. Epub 2021 Sep 9.
Int Immunopharmacol. 2021.
PMID: 34543980
Free PMC article.